José D. Pereira, Andreia Santos, Eugenia Cisneros-Barroso, Intissar Anan, Marina S. Lemos, Milena Paneque (2025). The other side of variant transthyretin amyloidosis with polyneuropathy: psychosocial experience of members of Portuguese families with late onset of the disease . Journal of Community Genetics.

Elena Moreno-Moraleda, Juan González-Moreno, Eugenia Cisneros-Barroso, María Antonia Ribot-Sansó, Tomás Ripoll-Vera, Cristina Descals, Mercedes Uson, Joan Carles Montalà, Antoni Figuerola, Adrián Rodríguez, et al. (2024). Validating the usefulness of Sudoscan in ATTRv: a single centre experience . Neurological Sciences.

Sodium–glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure @article{Cisneros_Barroso_2024, title={Sodium–glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure}, volume={26}, ISSN={1879-0844}, url={http://dx.doi.org/10.1002/ejhf.3321}, DOI={10.1002/ejhf.3321}, number={7}, journal={European Journal of Heart Failure}, publisher={Wiley}, author={Cisneros‐Barroso, Eugenia and Rossello, Xavier}, year={2024}, month=may, pages={1606–1607} } . European Journal of Heart Failure.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Sara Pérez-Martínez, Eugenia Cisneros-Barroso (2023). Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study . Orphanet Journal of Rare Diseases.

E. Cisneros-Barroso, F. Gorram, M. A. Ribot-Sansó, F. Alarcon, G. Nuel, J. González-Moreno, A. Rodríguez, J. Hernandez-Rodriguez, E. Amengual-Cladera, I. Martínez-López, et al. (2023). Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca . Orphanet Journal of Rare Diseases.

Violaine Planté-Bordeneuve, Farida Gorram, Malin Olsson, Intissar Anan, Anna Mazzeo, Luca Gentile, Eugenia Cisneros-Barroso, Juan Gonzalez-Moreno, Ines Losada, Marcia Waddington-Cruz, et al. (2023). A multicentric study of the disease risks and first manifestations in hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis . Amyloid.

Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota @article{Perell_Reus_2022, title={Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota}, volume={12}, ISSN={2234-943X}, url={http://dx.doi.org/10.3389/fonc.2022.995357}, DOI={10.3389/fonc.2022.995357}, journal={Frontiers in Oncology}, publisher={Frontiers Media SA}, author={Perelló-Reus, Catalina M. and Rubio-Tomás, Teresa and Cisneros-Barroso, Eugenia and Ibargüen-González, Lesly and Segura-Sampedro, Juan José and Morales-Soriano, Rafael and Barceló, Carles}, year={2022}, month=dec } . Frontiers in Oncology.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Eugenia Cisneros-Barroso (2022). Establishing Occupational Therapy Needs: A Semi-Structured Interview with Hereditary Transthyretin Amyloidosis Patients . International Journal of Environmental Research and Public Health.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, RIPOLL-VERA, TOMAS, Inés Losada, Margarita Gili, Milena Paneque, Cisneros-Barroso Eugenia (2022). Establishing Occupational Therapy Needs: A Semi-Structured Interview with Hereditary Transthyretin Amyloidosis Patients . International Journal of Environmental Research and Public Health.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Eugenia Cisneros-Barroso (2022). Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis . International Journal of Environmental Research and Public Health.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, RIPOLL-VERA, TOMAS, Inés Losada-López, Margarita Gili, Cisneros-Barroso Eugenia (2022). Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis . International Journal of Environmental Research and Public Health.

Eugenia Cisneros, Aina Darder, Ines Losada Lopez, Cristina Gomez-Bellvert, Adrian Rodriguez, Juan Gonzalez-Moreno (2021). Pulmonary nodular lymphoid hyperplasia and Sjögren’s syndrome: a case report and literature review . Rheumatology International.

Sancho-López A, Caballero-Bermejo AF, Ruiz-Antorán B, Múñez Rubio E, García Gasalla M, Buades J, González Rozas M, López Veloso M, Muñoz Gómez A, SARTRE-Study Group(2021). Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study) . Infectious diseases and therapy.

Juan Gonz{\'{a}}lez-Moreno and In{\'{e}}s Losada-L{\'{o}}pez and Eugenia Cisneros-Barroso and Pablo Garcia-Pavia and Jos{\'{e}} Gonz{\'{a}}lez-Costello and Francisco Mu{\~{n}}oz-Beamud and Josep Maria Campistol and Roberto Fernandez-Torron and Doug Chapman and Leslie Amass(2021). A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey . Neurology and Therapy. Springer Science and Business Media {LLC}

González-Moreno, J., Losada-López, I., Cisneros-Barroso, E., Garcia-Pavia, P., González-Costello, J., Muñoz-Beamud, F., Campistol, J. M., Fernandez-Torron, R., Chapman, D., & Amass, L. (2021). A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey. Neurology and therapy, 10.1007/s40120-021-00267-y. Advance online publication. https://doi.org/10.1007/s40120-021-00267-y .

(2021). Pulmonary nodular lymphoid hyperplasia and Sjögren's syndrome: a case report and literature review . Rheumatology international.

Juan González-Moreno, Aina Gaya-Barroso, Inés Losada-López, Adrián Rodríguez, Teresa Bosch-Rovira, Tomás Ripoll-Vera, Mercedes Usón, Antoni Figuerola, Cristina Descals, Carles Montalà, et al.(2021). Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden . Orphanet Journal of Rare Diseases. 16. (1). Springer Science and Business Media {LLC}

Juan Gonz{\'{a}}lez-Moreno and Aina Gaya-Barroso and In{\'{e}}s Losada-L{\'{o}}pez and Adri{\'{a}}n Rodr{\'{\i}}guez and Teresa Bosch-Rovira and Tom{\'{a}}s Ripoll-Vera and Mercedes Us{\'{o}}n and Antoni Figuerola and Cristina Descals and Carles Montal{\`{a}} and Mar{\'{\i}}a Asunci{\'{o}}n Ferrer-Nadal and Eugenia Cisneros-Barroso(2021). Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden . Orphanet Journal of Rare Diseases. 16. (1). Springer Science and Business Media {LLC}

David Adams and Michael Polydefkis and Alejandra Gonz{\'{a}}lez-Duarte and Jonas Wixner and Arnt V Kristen and Hartmut H Schmidt and John L Berk and In{\'{e}}s Asunci{\'{o}}n Losada L{\'{o}}pez and Angela Dispenzieri and Dianna Quan and Isabel M Concei{\c{c}}{\~{a}}o and Michel S Slama and Julian D Gillmore and Theodoros Kyriakides and Senda Ajroud-Driss and M{\'{a}}rcia Waddington-Cruz and Michelle M Mezei and Violaine Plant{\'{e}}-Bordeneuve and Shahram Attarian and Elizabeth Mauricio and Thomas H Brannagan and Mitsuharu Ueda and Emre Aldinc and Jing Jing Wang and Matthew T White and John Vest and Erhan Berber and Marianne T Sweetser and Teresa Coelho and Giuseppe Vita and Vincenzo Rizzo and Massimo Russo and Anna Mazzeo and Luca Gentile and John L Berk and Caitlin Brueckner and Victoria Lazzari and Janice Wiesman and Douglas DeLong and Jennifer Victory and James Dalton and John May and Catherine Gilmore and Shahram Attarian and Saran Diallo and Emilien Delmont and Jean Pouget and Annie Verschueren and Aude-Marie Grapperon and Emmanuelle Campana-Salort and Isabel M Concei{\c{c}}{\~{a}}o and Ana Lopes and Filipa Lamas and Carlos Neves and Jose Castro and Pedro Pereira and Isabel Castro and Ana Franco and Miguel Oliveira Santos and Concei{\c{c}}{\~{a}}o de Azevedo Coutinho and Catarina Falcao de Campos and Teresa Coelho and Antonio Hip{\'{o}}lito Reis and Nuno Correia and Javier M Perez and Ana Martins da Silva and Cristina Alves and Marcio Cardoso and Katia Valdrez and Julia R Monte and Bernardete Pessoa and Nadia Guimaraes and Monica Freitas and Joana Ramalho and Natalia Ferreira and Daisuke Kuzume and Celine Tard and Nawal Waucquier and Isabelle Rougeaux and Sylvie Brice and Emmanuelle Kasprzyk and Elise Elrezzi and Sayah Meguig and Eric Hachulla and Clement Gauvain and Maria-Claire Migaud-Chervy and Dominique Deplanque and Elsa Jozefowicz and Loic Lebellec and David Adams and Line Balaya-Gouraya and Nathalie Jehan Lacour and Halima Bournane and Nathalie Martin and Mongia Elabed and Niamey Sacko and Yasmine Boubrit and Amina Gaouar and Fetra Rakotondratafika and Marie Th{\'{e}}audin-Saliou and C{\'{e}}cile Cauquil-Michon and Celine Labeyrie and Adeline Not and Abdallah Al-Salameh and Anne-Lise Lecoq and Maeva Stephant and Andoni Echaniz-Laguna and Laurent Becquemont and Guillemette Beaudonnet and Vincent Algalarrondo and Ludivine Eliahou and Michel S Slama and Antoine Rousseau and Aissatou Signate and Emeline Berthelot and Jocelyn Inamo and Violaine Plant{\'{e}}-Bordeneuve and Laetitia Vervoitte and Cecile Focseneanu and Thierry Gendre and Raphaele Arrouasse and Samar S. Ayache and Laura Ernande and Philippe Le Corvoisier and Hayet Salhi and Ariane Choumert and Vincent Ehinger and Julie Ruiz and Cyril Charlin and Thomas Megelin and Thomas H Brannagan III and Raisy Fayerman and Arreum Kim and Allan Paras and Leidy J Gonzalez and Steven Tsang and Fernanda Wajnsztajn and Jeffrey Shije and Christina Ulane and Inna Kleyman and Louis Weimer and Comana Cioroiu and Sakis Lambrianides and Rana Abu-Manneh and Eleni Zamba-Papanicolaou and Petros Agathangelou and Eleni Leonidou and Satoshi Tada and Akemi Fujita and Masahiro Nagai and Rina Ando and Yuko Hosokawa and Yuki Yamanishi and J. Scott Overcash and Elena Giardino and Leslie Boyer and Lien Dang and An Le and Tyler Nguyen and Lien Giang and Peter Sellers and Leyla Tran and Nghi Truong and Maita Vinas and Nicole Hrkman and Sarah Miller and David Nguyen and Ashley Smith and Helen Pu and Steve Li and Thao Vuong and Holly Dioso and Sinikka Green and Kia Lee and Hanh Chu and Michael Waters and Derya J Coskun and Karla A Zepeda and William O{\textquotesingle}Riordan and Laura Obici and Andrea Cortese and Alessandro Lozza and Giampaolo Merlini and Vittorio Rosti and Mario Sabatelli and Giulia Bisogni and Daniela Bernardo and Marco Luigetti and Andrea Di Paolantonio and Valeria Guglielmino and Giulia Bisogni and Angela Romano and Hans Nienhuis and Janita Bulthuis-Kuiper and Arnt V Kristen and Olga Gerk and Hannah Ulbricht and Lenka Taylor and Eva Meyle and Natalia Kleinschmidt and David Meyrath and Simone Noe-Schwenn and Ulrike Meng and Ralf Bauer and Fabian aus dem Siepen and Selina Hein and Tetsuya Takahashi and Tomohiko Oshita and Yoko Koujin and Shuichiro Neshige and Tomohisa Nezu and Akiko Segawa and Hiroki Ueno and Hiroyuki Morino and Josep M Campistol and Lida Maria Rodas Marin and Josep Miquel Blasco Pelicano and Luc{\'{\i}}a Gal{\'{a}}n D{\'{a}}vila and Marta Palacios and Vanesa Pytel Cordoba and Antonio Guerrero Sola and Alejandro Horga and Juli{\'{a}}n Garc{\'{\i}}a Feijoo and Leopoldo Perez de Isla and Wilson Marques J{\'{u}}nior and Mariana Moscardini and Debora Cristina Litcanov and Ana Flavia Viera Lima and Leonardo Rodrigues and Barbara Marques Coutinho and Carolina Lavigne Moreira and Vanessa Daccach Marques and Francisco Munoz Beamud and {\'{A}}lvaro Gragera Mart{\'{\i}}nez and Cristina Borrachero and In{\'{e}}s Asunci{\'{o}}n Losada L{\'{o}}pez and Eugenia Cisneros Barroso and Adri{\'{a}}n Rodr{\'{\i}}guez Rodr{\'{\i}}guez and Monica Sanz and Elena Rigo Oliver and Juan Gonz{\'{a}}lez Moreno and Jose M Gamez Martinez and Cristina Descals and Mercedes Uson and Francisco Jose Vega and Antoni Figuerola and Carles Montala and M{\'{a}}rcia Waddington-Cruz and Moises Dias da Silva and Renata Gervais de Santa Rosa and Luiz Felipe Pinto and Marcus Vinicius Pinto and Amanda Cardoso Berensztejn and Fabio Barroso and Andrea Lautre and Lucas G Orellana and Maria Alejandra Gonz{\'{a}}lez-Duarte Brise{\~{n}}o and Karla C{\'{a}}rdenas-Soto and Brenda Poled Jim{\'{e}}nez L{\'{o}}pez and Sandra Lorena P{\'{e}}rez-Casta{\~{n}}eda and Carlos Gerardo Cant{\'{u}} Brito and David Rivera de la Parra and Jose Pablo Hernandez Reyes and Maria del Mar Saniger Alba and Elia Criollo Mora and Yesim Parman and Kus Jülide Rezzan and Erdi Sahin and Nail G Serbest and Hacer Durmus and Arman Cakar and Nuriye Ilknur Tugal Tutkun and Sacit Karamursel and Ali Elitok and Nermin G Sirin Inan and Emre Altinkurt and Michael Polydefkis and Jing Ye and Adriane C Allen and Vinay Chaudhry and Raquel Jarrett and Neil Bressler and Kathleen L Burks and Qingfeng Liu and Mohammad Khoshnoodi and Daniel P Judge and Geno Vista and Syed Mahmood Shah and Hirotoshi Hamaguchi and Junko Oda and Emi Fukase and Ikuko Taniguchi and Tetsuya Oda and Hironobu Endo and Masahiro Shimomura and Kimitaka Katanazaka and Shusuke Koto and Takahiro Nakano and Christof Scheid and Andreas Zueiter and Lars Pester and Doreen Walter and Betül Özdemir and Lukas F Frenzel and Udo Holtick and Jeeyoung Oh and Hee Jin Kim and Hyun Jin Shin and Kyomin Choi and Taro Yamashita and Mitsuharu Ueda and Teruaki Masuda and Yohei Misumi and Akihiko Ueda and Keiichi Nakahara and Akiko Yorita and Seiko Tsuruhisa and Takayuki Taniwaki and Masaya Harada and Taiga Moritaka and Naonori Sakurada and Elizabeth A Mauricio and Amber Baskin and Elliot Dimberg and Angela Dispenzieri and Amie Fonder and Miriam Hobbs and Stephen J Russell and Peter Dyck and Wilson Gonsalves and Nelson Leung and Thomas E Witzig and Steven R Zeldenrust and Lisa Hwa and Prashant Kapoor and Shaji K Kumar and Yi Lin and John A Lust and Vincent S Rajkumar and David Dingli and Morie A Gertz and Ronald Go and Suzanne R Hayman and Samir Dalia and Esmeralda Carrillo and Peter Gorevic and Garnette Mason and Chi-Chao Chao and Ming-Jen Lee and Jen-Jen Su and Sung-Tsang Hsieh and Li-Kai Tsai and Shin-Joe Yeh and Chih-Chao Yang and Senda Ajroud-Driss Ajroud-Driss and Patricia Casey and Benjamin C Joslin and Miriam Freimer and Alison Sankey and Amanda Kenepp and Sarah Heintzman and Samantha LoRusso and Youichi Hokezu and Byoung-Joon Kim and JuHyeon Kim and Ga Yeon Lee and Eun Bin Cho and Eun-Seok Jeon and Ju-Hong Min and Jin Myoung Seok and Hye Lim Lee and Jae Hong Park and Yoshiki Sekijima and Chinatsu Miyazawa and Nagaaki Kato and Dai Kishida and Akiyo Hineno and Minori Kodaira and Tsuneaki Yoshinaga and Teruyoshi Miyahara and Akira Imai and Kazuhiko Matsumoto and Kon-Ping Lin and Yi-Chung Lee and Jonas Wixner and Malin Falk and Bjorn Pilebro and Ole Suhr and Per Lindqvist and Karin Soderberg and Fatima Pedrosa-Domellöf and Intissar Anan and Erik Nordh and Ivaylo Tournev and Sashka Zhelyazkova-Glaveeva and Zheyna Cherneva and Staiko Sarafov and Teodora Chamova and Sylvia Cherninkova-Gopina and Hartmut H Schmidt and Frauke Friebel and Andree Zibert and Natasa Mihailovic and Friederike Schubert and Elena Vorona and Larissa Lahme and Anna Huesing-Kabar and Matthias Schilling and Iyad Kabar and Julian D Gillmore and Ana Martinez-Naharro and Liza Chacko and Oliver Cohen and Steven Law and Tamer Rezk and Helen J Lachmann and Dianna Quan and Brianna Blume and Stacy Dixon and Soon Chai Low and Soo Looi Chan and He Eng Li Lim and Khean Jin Goh and Michelle M Mezei and Deborah Kraus and Kristin Jack and N. Kevin Wade and Glenn Lopate and Brittany Zwijack and Julaine Florence and R. Brian Sommerville and Graeme Stewart and Julie Ryder and Linda Mekhael and Mark Taylor and Daniel Suan and Karen Wells and Paula Stone and Karen Wells and Amenze Itoya and Mercy Owusu-Sekyere and Desmond Thai and Ilonah Chahine and Salve Pedrosa and Thi Hoa (Therese) Do(2021). Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study . The Lancet Neurology. 20. (1). p. 49--59. Elsevier {BV}

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study @article{PMID:33212063, Title= {Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study}, Author= {Adams, David and Polydefkis, Michael and González-Duarte, Alejandra and Wixner, Jonas and Kristen, Arnt V and Schmidt, Hartmut H and Berk, John L and Losada López, Inés Asunción and Dispenzieri, Angela and Quan, Dianna and Conceição, Isabel M and Slama, Michel S and Gillmore, Julian D and Kyriakides, Theodoros and Ajroud-Driss, Senda and Waddington-Cruz, Márcia and Mezei, Michelle M and Planté-Bordeneuve, Violaine and Attarian, Shahram and Mauricio, Elizabeth and Brannagan, Thomas H and Ueda, Mitsuharu and Aldinc, Emre and Wang, Jing Jing and White, Matthew T and Vest, John and Berber, Erhan and Sweetser, Marianne T and Coelho, Teresa and {patisiran Global OLE study group}}, DOI= {10.1016/s1474-4422(20)30368-9}, Number= {1}, Volume= {20}, Month= {January}, Year= {2021}, Journal= {The Lancet. Neurology}, ISSN= {1474-4422}, Pages= {49—59}, Abstract= {<h4>Background</h4>Hereditary transthyretin-mediated amyloidosis is a rare, inherited, progressive disease caused by mutations in the transthyretin (TTR) gene. We assessed the safety and efficacy of long-term treatment with patisiran, an RNA interference therapeutic that inhibits TTR production, in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy.<h4>Methods</h4>This multicentre, open-label extension (OLE) trial enrolled patients at 43 hospitals or clinical centres in 19 countries as of Sept 24, 2018. Patients were eligible if they had completed the phase 3 APOLLO or phase 2 OLE parent studies and tolerated the study drug. Eligible patients from APOLLO (patisiran and placebo groups) and the phase 2 OLE (patisiran group) studies enrolled in this global OLE trial and received patisiran 0·3 mg/kg by intravenous infusion every 3 weeks with plans to continue to do so for up to 5 years. Efficacy assessments included measures of polyneuropathy (modified Neuropathy Impairment Score +7 [mNIS+7]), quality of life, autonomic symptoms, nutritional status, disability, ambulation status, motor function, and cardiac stress, with analysis by study groups (APOLLO-placebo, APOLLO-patisiran, phase 2 OLE patisiran) based on allocation in the parent trial. The global OLE is ongoing with no new enrolment, and current findings are based on the interim analysis of the patients who had completed 12-month efficacy assessments as of the data cutoff. Safety analyses included all patients who received one or more dose of patisiran up to the data cutoff. This study is registered with ClinicalTrials.gov, NCT02510261.<h4>Findings</h4>Between July 13, 2015, and Aug 21, 2017, of 212 eligible patients, 211 were enrolled: 137 patients from the APOLLO-patisiran group, 49 from the APOLLO-placebo group, and 25 from the phase 2 OLE patisiran group. At the data cutoff on Sept 24, 2018, 126 (92%) of 137 patients from the APOLLO-patisiran group, 38 (78%) of 49 from the APOLLO-placebo group, and 25 (100%) of 25 from the phase 2 OLE patisiran group had completed 12-month assessments. At 12 months, improvements in mNIS+7 with patisiran were sustained from parent study baseline with treatment in the global OLE (APOLLO-patisiran mean change -4·0, 95 % CI -7·7 to -0·3; phase 2 OLE patisiran -4·7, -11·9 to 2·4). Mean mNIS+7 score improved from global OLE enrolment in the APOLLO-placebo group (mean change from global OLE enrolment -1·4, 95% CI -6·2 to 3·5). Overall, 204 (97%) of 211 patients reported adverse events, 82 (39%) reported serious adverse events, and there were 23 (11%) deaths. Serious adverse events were more frequent in the APOLLO-placebo group (28 [57%] of 49) than in the APOLLO-patisiran (48 [35%] of 137) or phase 2 OLE patisiran (six [24%] of 25) groups. The most common treatment-related adverse event was mild or moderate infusion-related reactions. The frequency of deaths in the global OLE was higher in the APOLLO-placebo group (13 [27%] of 49), who had a higher disease burden than the APOLLO-patisiran (ten [7%] of 137) and phase 2 OLE patisiran (0 of 25) groups.<h4>Interpretation</h4>In this interim 12-month analysis of the ongoing global OLE study, patisiran appeared to maintain efficacy with an acceptable safety profile in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. Continued long-term follow-up will be important for the overall assessment of safety and efficacy with patisiran.<h4>Funding</h4>Alnylam Pharmaceuticals.}, URL= {https://doi.org/10.1016/S1474-4422(20)30368-9}} . The Lancet. Neurology.

(2020). Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster . Amyloid.

(2020). Multidisciplinary approach in the management of hATTR . European Journal of Clinical Investigation.

(2020). ePresentation Sessions . European Journal of Neurology. 27. (S1). p. 103-522.

Eugenia Cisneros-Barroso, Inés Losada-López, Juan González-Moreno, Juan Buades, Asunción Ferrer-Nadal, Tomás Ripoll-Vera, Mercedes Usón, Antoni Figuerola, Joan Carles Montalà, Cristina Descals, et al. (2019). Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report . Amyloid.

Significant reduction in proteinuria after treatment with tafamidis @article{Ferrer_Nadal_2019, title={Significant reduction in proteinuria after treatment with tafamidis}, volume={26}, ISSN={1744-2818}, url={http://dx.doi.org/10.1080/13506129.2019.1583186}, DOI={10.1080/13506129.2019.1583186}, number={sup1}, journal={Amyloid}, publisher={Informa UK Limited}, author={Ferrer-Nadal, Asuncion and Ripoll, Tomas and Uson, Mercedes and Figuerola, Antoni and Andreu, Hernan and Losada, Ines and Gonzalez, Juan and Cisneros-Barroso, Eugenia and Buades, Juan}, year={2019}, month=mar, pages={67–68} } . Amyloid.

Descals, Cristina AND Uson, Mercedes AND Montal{\`a}, Carles AND Figuerola, Antonio AND Losada, Ines AND Gonz{\'a}lez, Juan AND Ferrer, Asunci{\'o}n AND Cisneros, Eugenia(2019). P91-T Neurophysiological assessment of asymptomatic TTRVal50Met carriers (transthyretin amyloid polyneuropathy) from the endemic foci of Mallorca . {Elsevier BV}

Joel N. Buxbaum and Thomas Brannagan III and Juan Buades-Reinés and Eugenia Cisneros and Isabel Conceicao and Theodoros Kyriakides and Giampaolo Merlini and Laura Obici and Violaine Plante-Bordeneuve and Antoine Rousseau and Yoshiki Sekijima and Akira Imai and Márcia Waddington Cruz and Masahito Yamada(2019). Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis . Amyloid. 0. (0). p. 1-5. Taylor & Francis

Eugenia Cisneros, Tomás Ripoll-Vera, Juan Buades, Yolanda Gómez, Juana Núñez, Manuel Raya(2017). Daño cardiaco en una cohorte de pacientes con amiloidosis por transtiretina por la mutación Val30Met . Revista Española de Cardiología. Elsevier {BV}

Early diagnosis in patients with transthyretin familial amyloid polyneuropathy: A comparative study @article{Raya_Cruz_2017, title={Early diagnosis in patients with transthyretin familial amyloid polyneuropathy: A comparative study}, volume={148}, ISSN={2387-0206}, url={http://dx.doi.org/10.1016/j.medcle.2016.09.042}, DOI={10.1016/j.medcle.2016.09.042}, number={2}, journal={Medicina Clínica (English Edition)}, publisher={Elsevier BV}, author={Raya-Cruz, Manuel and Buades-Reines, Juan and Gállego-Lezáun, Cristina and Ripoll-Vera, Tomás and Usón-Martín, Mercedes and Cisneros-Barroso, Eugenia}, year={2017}, month=jan, pages={63–66} } . Medicina Clínica (English Edition).

Eugenia Cisneros, Tomás Ripoll-Vera, Juan Buades, Yolanda Gómez, Juana Núñez, Manuel Raya(2017). Daño cardiaco en una cohorte de pacientes con amiloidosis por transtiretina por la mutación Val30Met . Revista Española de Cardiologa.

Raya-Cruz, M., Buades-Reines, J., Gállego-Lezáun, C., Ripoll-Vera, T., Usón-Martín, M., Cisneros-Barroso, E.(2017). Early diagnosis in patients with transthyretin familial amyloid polyneuropathy: A comparative study . Med Clin (Barc). 148. (2). p. 63-66.

Genin, E. C., Plutino, M., Bannwarth, S., Villa, E., Cisneros-Barroso, E., Roy, M., Ortega-Vila, B., Fragaki, K., Lespinasse, F., Pinero-Martos, E., et al.(2016). CHCHD10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis . EMBO Mol Med. 8. (1). p. 58-72.

Piñero-Martos, E., Ortega-Vila, B., Pol-Fuster, J., Cisneros-Barroso, E., Ruiz-Guerra, L., Medina-Dols, A., Heine-Suñer, D., Lladó, J., Olmos, G., Vives-Bauzà, C.(2016). Disrupted in schizophrenia 1 (DISC1) is a constituent of the mammalian mitochondrial contact site and cristae organizing system (MICOS) complex, and is essential for oxidative phosphorylation . Hum Mol Genet. 25. (19). p. 4157-4169.

Buades-Reinés, J., Raya-Cruz, M., Gallego-Lezaún, C., Ripoll-Vera, T., Usón-Martín, M., Andreu-Serra, H., Cisneros-Barroso, E.(2016). Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease . J Peripher Nerv Syst. 21. (4). p. 352-356.

Cisneros-Barroso, E., Yance-Chávez, T., Kito, A., Sugiura, R., Gómez-Hierro, A., Giménez-Zaragoza, D., Aligue, R.(2014). Negative feedback regulation of calcineurin-dependent Prz1 transcription factor by the CaMKK-CaMK1 axis in fission yeast . Nucleic Acids Res. 42. (15). p. 9573-87.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Sara Pérez-Martínez, Cisneros-Barroso Eugenia (2024). Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study . figshare.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Sara Pérez-Martínez, Cisneros-Barroso Eugenia (2024). Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study . figshare.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Sara Pérez-Martínez, Cisneros-Barroso Eugenia (2024). Additional file 2 of Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study . figshare.

Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Sara Pérez-Martínez, Cisneros-Barroso Eugenia (2024). Additional file 2 of Occupational practice in patients with hereditary transthyretin amyloidosis, a qualitative study . figshare.

Isn't occupational therapy necessary in the Iberian Peninsula? A qualitative study. @article{Gay_Barroso_2023, title={Isn’t occupational therapy necessary in the Iberian Peninsula? A qualitative study.}, url={http://dx.doi.org/10.21203/rs.3.rs-3369094/v1}, DOI={10.21203/rs.3.rs-3369094/v1}, publisher={Research Square Platform LLC}, author={Gayà-Barroso, Aina and González-Moreno, Juan and Rodríguez, Adrián and Ripoll-Vera, Tomás and López, Inés Losada and Gili, Margarita and Cisneros-Barroso, Eugenia and Paneque, Milena}, year={2023}, month=sep } .

The Other Side of Variant Transthyretin Amyloidosis With Polyneuropathy: Psychosocial Experience of Members of Portuguese Families with Late Onset of the Disease @article{Pereira_2024, title={The Other Side of Variant Transthyretin Amyloidosis With Polyneuropathy: Psychosocial Experience of Members of Portuguese Families with Late Onset of the Disease}, url={http://dx.doi.org/10.21203/rs.3.rs-4384538/v1}, DOI={10.21203/rs.3.rs-4384538/v1}, publisher={Research Square Platform LLC}, author={Pereira, José D. and Santos, Andreia and Cisneros-Barroso, Eugenia and Anan, Intissar and Lemos, Marina S. and Paneque, Milena}, year={2024}, month=may } .

Val50Met Hereditary Transthyretin Amyloidosis: Not Just a Medical Problem, but a Psychosocial Burden @article{Gonz_lez_Moreno_2020, title={Val50Met Hereditary Transthyretin Amyloidosis: Not Just a Medical Problem, but a Psychosocial Burden}, url={http://dx.doi.org/10.21203/rs.3.rs-117451/v1}, DOI={10.21203/rs.3.rs-117451/v1}, publisher={Research Square Platform LLC}, author={González-Moreno, J and Losada-López, I and Rodríguez, A and Bosch-Rovira, T and Barroso, A Gaya and Ripoll-Vera, T and Usón, M and Figuerola, A and Descals, C and Montalà, C and Ferrer-Nadal, MA and Cisneros-Barroso, E}, year={2020}, month=dec } .